Can Vitamin D Supplements Prevent COVID-19 or Reduce Symptoms?
Funding from the National Institutes of Health will enable a Penn State researcher to study whether vitamin D supplementation could help people ward off or…
Funding from the National Institutes of Health will enable a Penn State researcher to study whether vitamin D supplementation could help people ward off or…
The antidepressant fluvoxamine appears to prevent COVID-19 infections from worsening and may help keep patients out of the hospital, a trial based on research from…
A study of nearly 2,000 Marine recruits who went through supervised quarantine before starting basic training revealed several instances of asymptomatic transmission of SARS-CoV-2, the…
MedUni Vienna study provides new information for a better understanding of the disease – and potential biomarkers for vaccine development. In a study recently published…
Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold…
Blood clots continue to wreak havoc for patients with severe COVID-19 infection, and a new study explains what may spark them in up to half…
Brigham investigators have identified patients who cleared the disease faster and had a persistent antibody response, with important implications for immunity. One of the pressing…
University of Pittsburgh School of Medicine scientists have discovered the fastest way to identify potent, neutralizing human monoclonal antibodies against SARS-CoV-2, the virus that causes…
Preclinical data published in Cell show the nanoparticle vaccine spurs extremely high levels of protective antibodies in animal models. An innovative nanoparticle vaccine candidate for…
New info on antibody levels in sicker patients and elderly could inform vaccine goals. As vaccine trials progress and public health officials brace for a…
New Clinical Study Aims to Better Understand COVID-19 Immunity People who have recovered from COVID-19, and their close contacts, could hold the key to understanding…
A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians…
Two separate studies have documented the persistence of antibodies that target SARS-CoV-2 in hundreds of patients with COVID-19 at least 3 months after symptom onset….
One way CBD appears to reduce the “cytokine storm” that damages the lungs and kills many patients with COVID-19 is by enabling an increase in…
As of October 2020, the ongoing pandemic caused by SARS-CoV-2 has resulted in more than 35 million reported cases and more than 1 million deaths…
Like a cold front that moves in, setting the stage for severe weather, coronavirus infection triggers showers of infection-fighting immune molecules — showers that sometimes…
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir…
While most COVID-19 cases are asymptomatic or mild, severe complications associated with acute respiratory distress have led to more than one million deaths worldwide in…